Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Olofsson, S.
Right arrow Articles by Bergstrom, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olofsson, S.
Right arrow Articles by Bergstrom, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, Vol 9, 73-81, Copyright © 1999 by Oxford University Press


ORIGINAL ARTICLES

The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC

S Olofsson, A Bolmstedt, M Biller, K Mardberg, J Leckner, BG Malmstrom, E Trybala and T Bergstrom
Department of Clinical Virology, University of Goteborg, Guldhedsgatan 10 B, S-413 46 Goteborg, Sweden.

A monoclonal antibody, B1C1, binding to an epitope of antigenic site II of the herpes simplex virus type 1 (HSV-1) glycoprotein gC-1, is a potent inhibitor of two important biological functions of gC-1: its binding to cell surface heparan sulfate and its binding to the receptor for complement factor C3b. Here, we have analyzed a B1C1-resistant HSV- 1 variant (HSV-12762/B1C1B4.2), obtained after passage of wild type HSV- 1 (HSV-12762) in the presence of high concentrations of B1C1. The transport of newly synthesized mutant gC-1 to the cell surface was comparable to that of wild type glycoprotein, but no binding of surface- associated mutant gC-1 to B1C1 was detected. However, mutant and wild type gC-1 bound equally well to other site II Mabs. Attachment of wild type but not mutant virus was inhibited by B1C1. Sequencing of the mutant gC-1 gene revealed only one nucleotide change, resulting in replacement of Thr150 by an Ile, in turn destroying an N-glycosylation site at Asn148. Loss of one complex type N-linked glycan was confirmed by endoglycosidase digestion and subsequent SDS-polyacrylamide gel electrophoresis. Circular dichroism analysis of purified gC-1 from cells infected with mutant or wild type virus did not reveal any difference in secondary structure between mutant and wild type gC-1. It was not possible to obtain a B1C1-resistant phenotype by nucleotide- directed mutagenesis of gC-1 where Asn148 was changed to a glutamine. These data demonstrated that the threonine of the glycosylation site and not the N-linked glycan in itself was essential for B1C1 binding
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
J. R. Teuton and C. R. Brandt
Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells
J. Virol., April 15, 2007; 81(8): 3731 - 3739.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
K. Mardberg, K. Nystrom, M. A. Tarp, E. Trybala, H. Clausen, T. Bergstrom, and S. Olofsson
Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity
Glycobiology, July 1, 2004; 14(7): 571 - 581.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. Mardberg, E. Trybala, J. C. Glorioso, and T. Bergstrom
Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C
J. Gen. Virol., August 1, 2001; 82(8): 1941 - 1950.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Bolmstedt, B. R. O'Keefe, S. R. Shenoy, J. B. McMahon, and M. R. Boyd
Cyanovirin-N Defines a New Class of Antiviral Agent Targeting N-Linked, High-Mannose Glycans in an Oligosaccharide-Specific Manner
Mol. Pharmacol., April 16, 2001; 59(5): 949 - 954.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
J.-A. Liljeqvist, B. Svennerholm, and T. Bergström
Conservation of Type-Specific B-Cell Epitopes of Glycoprotein G in Clinical Herpes Simplex Virus Type 2 Isolates
J. Clin. Microbiol., December 1, 2000; 38(12): 4517 - 4522.
[Abstract] [Full Text]


Home page
GlycobiologyHome page
M. Biller, K. Mardberg, H. Hassan, H. Clausen, A. Bolmstedt, T. Bergstrom, and S. Olofsson
Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties
Glycobiology, December 1, 2000; 10(12): 1259 - 1269.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-A. Liljeqvist, B. Svennerholm, and T. Bergström
Herpes Simplex Virus Type 2 Glycoprotein G-Negative Clinical Isolates Are Generated by Single Frameshift Mutations
J. Virol., December 1, 1999; 73(12): 9796 - 9802.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
J.-A. Liljeqvist, B. Svennerholm, and T. Bergström
Typing of Clinical Herpes Simplex Virus Type 1 and Type 2 Isolates with Monoclonal Antibodies
J. Clin. Microbiol., August 1, 1999; 37(8): 2717 - 2718.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.